Veru VERU
NASDAQ VERU
$2.51 -0.03 (-1.18%)
At close: Oct 2, 2026 · 4:00 PM EDT

Veru (VERU) Liabilities from Discontinued Operations (2024)

Updated

Veru (VERU) reported Liabilities from Discontinued Operations of $16,071 for fiscal Q4 2024 (quarter ended Sep 30, 2024).

Analysis

Veru (VERU) Liabilities from Discontinued Operations (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Veru 57.86 Mn -52.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 16,071.00
API Access

Veru Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=VERU&period=max&api_key=YOUR_API_KEY